Authors: GECZI L HORVATH Z BODROGI I

Citation: L. Geczi et al., EARLY DETECTION PROGRAM FOR TESTICULAR CANCER IN HUNGARY - 3 YEARS RESULTS, Annals of oncology, 9, 1998, pp. 266-266

Authors: EID H GECZI L MAGORI A BODROGI I INSTITORIS E BAK M

Citation: H. Eid et al., DRUG-RESISTANCE AND SENSITIVITY OF GERM-CELL TESTICULAR-TUMORS - EVALUATION OF CLINICAL RELEVANCE OF MDR1 PGP, P53, AND METALLOTHIONEIN (MT) PROTEINS/, Anticancer research, 18(4C), 1998, pp. 3059-3064

Authors: EID H GECZI L BODROGI I INSTITORIS E BAK M

Citation: H. Eid et al., DO METALLOTHIONEINS AFFECT THE RESPONSE TO TREATMENT IN TESTIS CANCERS, Journal of cancer research and clinical oncology, 124(1), 1998, pp. 31-36

Authors: EID H GULYAS M GECZI L BODROGI I INSTITORIS E BAK M

Citation: H. Eid et al., EXPRESSION OF BCL-2 IN TESTICULAR-CARCINOMA - CORRELATION WITH TUMOR PROGRESSION AND MDR1 PGP/, Cancer, 83(2), 1998, pp. 331-336

Authors: INSTITORIS E EID H BODROGI I GECZI L BAK M

Citation: E. Institoris et al., EXPRESSION OF P53, WAF1, MDM2 AND BCL-2 PROTEINS IN HUMAN GERM-CELL TESTICULAR-TUMORS, British Journal of Cancer, 78, 1998, pp. 17-17

Authors: EID H VANDERLOOIJ M INSTITORIS E GECZI L BODROGI I OLAH E BAK M

Citation: H. Eid et al., IS P53 EXPRESSION, DETECTED BY IMMUNOHISTOCHEMISTRY, AN IMPORTANT PARAMETER OF RESPONSE TO TREATMENT IN TESTIS CANCER, Anticancer research, 17(4A), 1997, pp. 2663-2669